Grant winners

August 2, 2012

ARTS AND HUMANITIES RESEARCH COUNCIL

Research Grants

Extended knowledge

From explanation to ethics and back again

Orientations in the development of Pan-Arab television for children

LEVERHULME TRUST

Research Project Grants

Sciences

  • Award winner: Dek Woolfson
  • Institution: University of Bristol
  • Value: £143,611

The design, assembly and functionalisation of peptide nanotubes

  • Award winner: Joseph Jackson
  • Institution: Aberystwyth University
  • Value: £242,019

Thermal variation and immunity in ectothermic vertebrates

  • Award winner: Eric Barnard
  • Institution: University of Cambridge
  • Value: £74,598

Assemblies and migrations of native P2Y ATP-receptors in the developing brain

ECONOMIC AND SOCIAL RESEARCH COUNCIL

Research Seminar Awards

Political science and international studies

The future of American power

Social policy

  • Award winner: Joanna Richardson
  • Institution: De Montfort University
  • Value: £14,694

Creating space and place for Roma, gypsies and travellers: resolving conflict

  • Award winner: Alex Nicholls
  • Institution: University of Oxford
  • Value: £14,807

Reconstructing social enterprise

  • Award winner: Christina Victor
  • Institution: Brunel University
  • Value: £17,950

Ageing, race and ethnicity

  • Award winner: Lesley Hoggart
  • Institution: University of Greenwich
  • Value: £13,513

Understandings of the young sexual body

IN DETAIL

National Institute for Health Research

Award winner: David Fitzmaurice

Institution: University of Birmingham

Value: £226,482

The development and evaluation of a prognostic model and clinical decision rule to help decide on cessation of anticoagulant therapy in patients with idiopathic venous thromboembolism (VTE)

This project aims to provide a rule that can identify patients who have suffered embolisms but who are at very low risk of further blood clots in either their legs or lungs. At the moment patients who suffer blood clots in these areas are treated for three to 12 months with oral anticoagulants because doctors are unsure about how long they should be treated. Lengthy treatment can cause problems, however, and some patients will develop further clots however long they are treated. It is important therefore that doctors are able to identify patients for whom it is safe to stop after routine treatment so that they can concentrate resources on those who need it. The study will utilise a large database of information to try to formulate the rule.

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments